Navigation Links
Cancer Prevention Coalition: The Breast Cancer Awareness Month Misleads Women

CHICAGO, Oct. 16 /PRNewswire-USNewswire/ -- In 1984, the American Cancer Society (ACS) inaugurated the National Breast Cancer Awareness Month (NBCAM), with its October 17 flagship National Mammography Day. The NBCAM was conceived and funded by the Imperial Chemical Industries, a leading international manufacturer of petrochemicals, and its U.S. subsidiary Zeneca Pharmaceuticals. Zeneca is the sole manufacturer of Tamoxifen, claimed to reduce risks of breast cancer, even though it is toxic and carcinogenic.

The NBCAM assured women that "early (mammography) detection results in a cure nearly 100% of the time." More specifically, the NBCAM is primarily directed to claims for reducing the incidence and mortality of breast cancer through early detection by annual mammography starting at age 40.

Still unrecognized by the ACS, and also the National Cancer Institute (NCI), is strong evidence that mammography poses significant risks of breast cancer. The routine practice of taking four films annually for each breast results in approximately 1 rad (radiation absorbed dose) exposure, which is approximately 1,000 times the dose from a single chest X-ray. Each rad exposure increases risks of breast cancer by about one percent, with a cumulative 10 percent increased risk for each breast over a decade's screening. Moreover, the premenopausal breast is highly sensitive to radiation. Not surprisingly, premenopausal mammography screening is practiced by no nation other than the U.S.

Risks of premenopausal mammography are some four-fold greater for the one to two percent of women who are carriers of the A-T gene (ataxia telangiectasia), and highly sensitive to the carcinogenic effects of radiation. By some estimates, this accounts for up to 20 percent of all breast cancers diagnosed annually.

Compounding these problems, missed cancers are common in premenopausal women due to the density of their breasts.

That most breast cancers are first recognized by women was admitted in 1985 by the ACS. "We must keep in mind that at least 90% of the women who develop breast cancer discover the tumors themselves." Furthermore, an analysis of several 1993 studies showed that women who regularly performed breast self-examination (BSE) detected their cancers much earlier than women failing to examine themselves. The effectiveness of BSE however depends on training by skilled professionals, enhanced by annual clinical breast examination by a professional. In spite of such evidence, the ACS and radiologists dismiss BSE, and claim that "no studies have clearly shown the benefit of using BSE."

A leading Massachusetts newspaper featured a photograph of two women in their twenties in an ACS advertisement that promised early detection by mammography results in a cure "nearly 100 percent of the time." An ACS communications director, questioned by journalist Kate Dempsey, responded in an article published in the Massachusetts Women's Community's journal Cancer "The ad isn't based on a study. When you make an advertisement, you just say what you can to get women in the door. You exaggerate a point ... Mammography today is a lucrative [and] highly competitive business." She just couldn't be any more correct.

With this background, it is not surprising that the NBCAM neglects to inform women how they can reduce their risks of breast cancer. In fact, we know a great deal about its avoidable causes which are trivialized or ignored by the ACS. These include:

-- Prolonged use of the Pill or estrogen replacement therapy.

-- High consumption of meat which is heavily contaminated with potent

natural or synthetic estrogens, or other sex hormones, implanted in

cattle in feedlots prior to slaughter to increase muscle mass.

-- Prolonged consumption of milk from cows injected with a genetically

engineered growth hormone to increase milk production. This milk is

contaminated with high levels of a natural growth factor, which

increases breast cancer risks by up to seven-fold.

-- Prolonged exposure to a wide range of unlabeled hormonal ingredients in

cosmetics and personal care products.

-- Living near hazardous waste sites, petrochemical plants, power lines,

and nuclear plants.

-- Occupational exposures of over one million women to carcinogens. These

include benzene, ethylene oxide, methylene chloride, phenylenediamine

hair dyes, and agricultural pesticides, including DDT residues.

Samuel S. Epstein, M.D.

Professor emeritus Environmental & Occupational Medicine

University of Illinois at Chicago School of Public Health,

Chairman, Cancer Prevention Coalition

Chicago, Illinois;

Rosalie Bertell, PhD

Former President of the International Institute of Concern for Public Health,Toronto, Canada

Regent of the International Physicians for Humanitarian Medicine, Geneva, Switzerland

SOURCE Cancer Prevention Coalition
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Vitamin B12 can help in detecting cancers
6. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
7. Consensus on "Combination Therapy" for Breast Cancer
8. Cancers of Colon & Rectum linked to Cigarette Smoking
9. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
10. The Cancer Rumour mill working over time
11. Want skin cancer? Please have a cigarette
Post Your Comments:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing an ... to overcome a rare and deadly chromosome abnormality. , After struggling since birth ...
(Date:10/13/2017)... ... 13, 2017 , ... While it’s often important to take certain medications during ... Austin, Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP ... such, it eliminates the need to turn on a light when taking medication during ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... New York, NY (PRWEB) , ... October 13, 2017 , ... ... most influential people in business to advocate for action towards gender equality at their ... 18,000 views from around the globe, and reached a social audience of over 3 ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... IRVING, Texas , Oct. 11, 2017  Caris ... science focused on fulfilling the promise of precision medicine, ... Institute has joined Caris, Precision Oncology Alliance™ (POA) as ... leading cancer centers, the St. Jude Crosson Cancer Institute ... to advance the use of tumor profiling, making cancer ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
Breaking Medicine Technology: